While these findings may invoke safety concern on the use of GAS6-CAR-T cells, the affinity between natural ligands and receptors is usually lower than that between antigens and antibodies, and natural ligands-based CAR will probably efficiently attack tumor cells with higher target expression, but spare normal cells with lower target expression [35]. This evidence concerns the gene GAS6 and neoplasm.